Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.3% versus 0.1% sodium hyaluronate eyedrops after LASIK
ChiCTR-IPR-16007940Phase 4Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium hyaluronate in dry eye syndrome (DED) (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: Visual analogue scale, Ocular Surface Disease Index questionnaire and 7 more. Started Feb 2016; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR-IPR-16007940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007940.